BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8228348)

  • 1. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages.
    Perno CF; Bergamini A; Pesce CD; Milanese G; Capozzi M; Aquaro S; Thaisrivongs S; Tarpley WG; Zon G; D'Agostini C
    J Infect Dis; 1993 Nov; 168(5):1148-56. PubMed ID: 8228348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
    Perno CF; Newcomb FM; Davis DA; Aquaro S; Humphrey RW; Caliò R; Yarchoan R
    J Infect Dis; 1998 Aug; 178(2):413-22. PubMed ID: 9697721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages.
    Perno CF; Aquaro S; Rosenwirth B; Balestra E; Peichl P; Billich A; Villani N; Caliò R
    J Leukoc Biol; 1994 Sep; 56(3):381-6. PubMed ID: 8083612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity.
    Alteri E; Bold G; Cozens R; Faessler A; Klimkait T; Lang M; Lazdins J; Poncioni B; Roesel JL; Schneider P
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2087-92. PubMed ID: 8257128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
    Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR
    Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
    Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease.
    Jacobsen H; Ahlborn-Laake L; Gugel R; Mous J
    J Virol; 1992 Aug; 66(8):5087-91. PubMed ID: 1378515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.
    Davis DA; Branca AA; Pallenberg AJ; Marschner TM; Patt LM; Chatlynne LG; Humphrey RW; Yarchoan R; Levine RL
    Arch Biochem Biophys; 1995 Sep; 322(1):127-34. PubMed ID: 7574666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
    Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
    J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.
    Yamaguchi K; Papp B; Zhang D; Ali AN; Agrawal S; Byrn RA
    AIDS Res Hum Retroviruses; 1997 May; 13(7):545-54. PubMed ID: 9135872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha.
    Pagano PJ; Chong KT
    J Infect Dis; 1995 Jan; 171(1):61-7. PubMed ID: 7528253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
    Lund OS; Nielsen JO; Hansen JE
    Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
    Zelphati O; Zon G; Leserman L
    Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
    Lisziewicz J; Sun D; Weichold FF; Thierry AR; Lusso P; Tang J; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7942-6. PubMed ID: 8058738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase.
    Nagy K; Young M; Baboonian C; Merson J; Whittle P; Oroszlan S
    J Virol; 1994 Feb; 68(2):757-65. PubMed ID: 8289379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease.
    Pretzer E; Flasher D; Düzgüneş N
    Antiviral Res; 1997 Mar; 34(1):1-15. PubMed ID: 9107381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages.
    Borrajo A; Ranazzi A; Pollicita M; Bruno R; Modesti A; Alteri C; Perno CF; Svicher V; Aquaro S
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28956865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.
    Ashorn P; McQuade TJ; Thaisrivongs S; Tomasselli AG; Tarpley WG; Moss B
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7472-6. PubMed ID: 2217178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.
    Nakashima H; Shoji Y; Kim SG; Shimada J; Mizushima Y; Ito M; Yamamoto N; Takaku H
    Nucleic Acids Res; 1994 Nov; 22(23):5004-10. PubMed ID: 7528375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.